Literature DB >> 12640708

[Correlation of rdxA gene mutation and metronidazole resistance of Helicobacter pylori].

Ning Dai1, Gang Zhou, Jie Yan.   

Abstract

OBJECTIVE: To demonstrate the correlation of rdxA gene mutation and metronidazole (MTZ) resistance of H.pylori isolates in the local area.
METHODS: Clinical strains of H.pylori were isolated from gastric biopsy of patients. Resistance to metronidazole of the isolates was determined by using diffusion test and two fold dilution test. Genome DNAs of the isolates were prepared for PCR to detect rdxA gene. The target amplification products were sequenced after T-A cloning. The sequences were compared with the reported sequences from Hp26695 and 134 other strains of H.pylori.
RESULTS: MTZ resistance rate was 76.1% in 21 clinical isolates. The target fragment 886 bp in length containing rdxA gene could be successfully amplified. In comparison with the reported corresponding sequence of H.pylori stain 26695, homologies of the nucleotide sequences from the amplification products were 90.1% approximate, equals 95.1%. Mutations caused by base insertion/deletion and substitution in the MTZ resistance isolates were found. Among these mutations, two types of insertion mutations have not been reported in literatures. No same mutations were present in the MTZ sensitive isolates.
CONCLUSION: The rdxA gene mutation may play an important role in MTZ resistance of H.pylori.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12640708

Source DB:  PubMed          Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban        ISSN: 1008-9292


  3 in total

1.  Helicobacter pylori antibiotic resistance in Iran.

Authors:  Marjan Mohammadi; Delaram Doroud; Nazanin Mohajerani; Sadegh Massarrat
Journal:  World J Gastroenterol       Date:  2005-10-14       Impact factor: 5.742

2.  Screening for metronidazole-resistance associated gene fragments of H pylori by suppression subtractive hybridization.

Authors:  Ai-Qing Li; Ning Dai; Jie Yan; Yong-Liang Zhu
Journal:  World J Gastroenterol       Date:  2007-03-28       Impact factor: 5.742

3.  Drug utilization of clarithromycin for gastrointestinal disease treatment.

Authors:  Quan Zhou; Ling-Ling Zhu; Xiao-Feng Yan; Wen-Sheng Pan; Su Zeng
Journal:  World J Gastroenterol       Date:  2008-10-21       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.